ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Biosimilars Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-38I13568
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Biosimilars Drug Market Research Report 2023
BUY CHAPTERS

Global Biosimilars Drug Market Research Report 2025

Code: QYRE-Auto-38I13568
Report
May 2025
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Qilu Pharmaceutical
Zhejiang Hisun
Innovent Biologics
Jiangsu Hengrui
Gan & Lee
Tonghua Dongbao
United Laboratory
3SBio Inc
Luye Pharma
Celltrion
Pfizer Inc
Novartis
Dr. Reddy's
Celgen Biopharma
Eli Lilly
Sanofi
Geropharm
Biocon Ltd.
WOCKHARDT
Bio-Thera
Shanghai Henlius

Biosimilars Drug Market Size

The global market for Biosimilars Drug was valued at US$ 4868 million in the year 2024 and is projected to reach a revised size of US$ 22870 million by 2031, growing at a CAGR of 25.1% during the forecast period.

Biosimilars Drug Market

Biosimilars Drug Market

A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original product that manufactured by a different company. Biosimilar are officially approved versions of original "innovator" products and can manufactured when the original product"s patent expires. Reference to the innovator product is an integral component of the approval.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Biosimilars Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biosimilars Drug.
The Biosimilars Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biosimilars Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biosimilars Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Biosimilars Drug Market Report

Report Metric Details
Report Name Biosimilars Drug Market
Accounted market size in year US$ 4868 million
Forecasted market size in 2031 US$ 22870 million
CAGR 25.1%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Qilu Pharmaceutical, Bio-Thera, Zhejiang Hisun, Shanghai Henlius, Innovent Biologics, Jiangsu Hengrui, Gan&Lee, Tonghua Dongbao, United Laboratory, 3SBIO, Luye Pharma, Celltrion, Pfizer, Novartis, Dr Reddy’s, Celgen Biopharma, Eli Lilly, Sanofi, Geropharm, Biocon, Wockhardt
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Biosimilars Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Biosimilars Drug Market growing?

Ans: The Biosimilars Drug Market witnessing a CAGR of 25.1% during the forecast period 2025-2031.

What is the Biosimilars Drug Market size in 2031?

Ans: The Biosimilars Drug Market size in 2031 will be US$ 22870 million.

Who are the main players in the Biosimilars Drug Market report?

Ans: The main players in the Biosimilars Drug Market are Qilu Pharmaceutical, Bio-Thera, Zhejiang Hisun, Shanghai Henlius, Innovent Biologics, Jiangsu Hengrui, Gan&Lee, Tonghua Dongbao, United Laboratory, 3SBIO, Luye Pharma, Celltrion, Pfizer, Novartis, Dr Reddy’s, Celgen Biopharma, Eli Lilly, Sanofi, Geropharm, Biocon, Wockhardt

What are the Application segmentation covered in the Biosimilars Drug Market report?

Ans: The Applications covered in the Biosimilars Drug Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Biosimilars Drug Market report?

Ans: The Types covered in the Biosimilars Drug Market report are Monoclonal Antibodies, Insulin, Others

Recommended Reports

Biological Pharmaceuticals

Pharmaceutical Drug Markets

Drug Delivery & Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilars Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibodies
1.2.3 Insulin
1.2.4 Others
1.3 Market by Application
1.3.1 Global Biosimilars Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimilars Drug Market Perspective (2020-2031)
2.2 Global Biosimilars Drug Growth Trends by Region
2.2.1 Global Biosimilars Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Biosimilars Drug Historic Market Size by Region (2020-2025)
2.2.3 Biosimilars Drug Forecasted Market Size by Region (2026-2031)
2.3 Biosimilars Drug Market Dynamics
2.3.1 Biosimilars Drug Industry Trends
2.3.2 Biosimilars Drug Market Drivers
2.3.3 Biosimilars Drug Market Challenges
2.3.4 Biosimilars Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilars Drug Players by Revenue
3.1.1 Global Top Biosimilars Drug Players by Revenue (2020-2025)
3.1.2 Global Biosimilars Drug Revenue Market Share by Players (2020-2025)
3.2 Global Biosimilars Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Biosimilars Drug Revenue
3.4 Global Biosimilars Drug Market Concentration Ratio
3.4.1 Global Biosimilars Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilars Drug Revenue in 2024
3.5 Global Key Players of Biosimilars Drug Head office and Area Served
3.6 Global Key Players of Biosimilars Drug, Product and Application
3.7 Global Key Players of Biosimilars Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilars Drug Breakdown Data by Type
4.1 Global Biosimilars Drug Historic Market Size by Type (2020-2025)
4.2 Global Biosimilars Drug Forecasted Market Size by Type (2026-2031)
5 Biosimilars Drug Breakdown Data by Application
5.1 Global Biosimilars Drug Historic Market Size by Application (2020-2025)
5.2 Global Biosimilars Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Biosimilars Drug Market Size (2020-2031)
6.2 North America Biosimilars Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Biosimilars Drug Market Size by Country (2020-2025)
6.4 North America Biosimilars Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biosimilars Drug Market Size (2020-2031)
7.2 Europe Biosimilars Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Biosimilars Drug Market Size by Country (2020-2025)
7.4 Europe Biosimilars Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biosimilars Drug Market Size (2020-2031)
8.2 Asia-Pacific Biosimilars Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Biosimilars Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Biosimilars Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biosimilars Drug Market Size (2020-2031)
9.2 Latin America Biosimilars Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Biosimilars Drug Market Size by Country (2020-2025)
9.4 Latin America Biosimilars Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biosimilars Drug Market Size (2020-2031)
10.2 Middle East & Africa Biosimilars Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Biosimilars Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Biosimilars Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Qilu Pharmaceutical
11.1.1 Qilu Pharmaceutical Company Details
11.1.2 Qilu Pharmaceutical Business Overview
11.1.3 Qilu Pharmaceutical Biosimilars Drug Introduction
11.1.4 Qilu Pharmaceutical Revenue in Biosimilars Drug Business (2020-2025)
11.1.5 Qilu Pharmaceutical Recent Development
11.2 Bio-Thera
11.2.1 Bio-Thera Company Details
11.2.2 Bio-Thera Business Overview
11.2.3 Bio-Thera Biosimilars Drug Introduction
11.2.4 Bio-Thera Revenue in Biosimilars Drug Business (2020-2025)
11.2.5 Bio-Thera Recent Development
11.3 Zhejiang Hisun
11.3.1 Zhejiang Hisun Company Details
11.3.2 Zhejiang Hisun Business Overview
11.3.3 Zhejiang Hisun Biosimilars Drug Introduction
11.3.4 Zhejiang Hisun Revenue in Biosimilars Drug Business (2020-2025)
11.3.5 Zhejiang Hisun Recent Development
11.4 Shanghai Henlius
11.4.1 Shanghai Henlius Company Details
11.4.2 Shanghai Henlius Business Overview
11.4.3 Shanghai Henlius Biosimilars Drug Introduction
11.4.4 Shanghai Henlius Revenue in Biosimilars Drug Business (2020-2025)
11.4.5 Shanghai Henlius Recent Development
11.5 Innovent Biologics
11.5.1 Innovent Biologics Company Details
11.5.2 Innovent Biologics Business Overview
11.5.3 Innovent Biologics Biosimilars Drug Introduction
11.5.4 Innovent Biologics Revenue in Biosimilars Drug Business (2020-2025)
11.5.5 Innovent Biologics Recent Development
11.6 Jiangsu Hengrui
11.6.1 Jiangsu Hengrui Company Details
11.6.2 Jiangsu Hengrui Business Overview
11.6.3 Jiangsu Hengrui Biosimilars Drug Introduction
11.6.4 Jiangsu Hengrui Revenue in Biosimilars Drug Business (2020-2025)
11.6.5 Jiangsu Hengrui Recent Development
11.7 Gan&Lee
11.7.1 Gan&Lee Company Details
11.7.2 Gan&Lee Business Overview
11.7.3 Gan&Lee Biosimilars Drug Introduction
11.7.4 Gan&Lee Revenue in Biosimilars Drug Business (2020-2025)
11.7.5 Gan&Lee Recent Development
11.8 Tonghua Dongbao
11.8.1 Tonghua Dongbao Company Details
11.8.2 Tonghua Dongbao Business Overview
11.8.3 Tonghua Dongbao Biosimilars Drug Introduction
11.8.4 Tonghua Dongbao Revenue in Biosimilars Drug Business (2020-2025)
11.8.5 Tonghua Dongbao Recent Development
11.9 United Laboratory
11.9.1 United Laboratory Company Details
11.9.2 United Laboratory Business Overview
11.9.3 United Laboratory Biosimilars Drug Introduction
11.9.4 United Laboratory Revenue in Biosimilars Drug Business (2020-2025)
11.9.5 United Laboratory Recent Development
11.10 3SBIO
11.10.1 3SBIO Company Details
11.10.2 3SBIO Business Overview
11.10.3 3SBIO Biosimilars Drug Introduction
11.10.4 3SBIO Revenue in Biosimilars Drug Business (2020-2025)
11.10.5 3SBIO Recent Development
11.11 Luye Pharma
11.11.1 Luye Pharma Company Details
11.11.2 Luye Pharma Business Overview
11.11.3 Luye Pharma Biosimilars Drug Introduction
11.11.4 Luye Pharma Revenue in Biosimilars Drug Business (2020-2025)
11.11.5 Luye Pharma Recent Development
11.12 Celltrion
11.12.1 Celltrion Company Details
11.12.2 Celltrion Business Overview
11.12.3 Celltrion Biosimilars Drug Introduction
11.12.4 Celltrion Revenue in Biosimilars Drug Business (2020-2025)
11.12.5 Celltrion Recent Development
11.13 Pfizer
11.13.1 Pfizer Company Details
11.13.2 Pfizer Business Overview
11.13.3 Pfizer Biosimilars Drug Introduction
11.13.4 Pfizer Revenue in Biosimilars Drug Business (2020-2025)
11.13.5 Pfizer Recent Development
11.14 Novartis
11.14.1 Novartis Company Details
11.14.2 Novartis Business Overview
11.14.3 Novartis Biosimilars Drug Introduction
11.14.4 Novartis Revenue in Biosimilars Drug Business (2020-2025)
11.14.5 Novartis Recent Development
11.15 Dr Reddy’s
11.15.1 Dr Reddy’s Company Details
11.15.2 Dr Reddy’s Business Overview
11.15.3 Dr Reddy’s Biosimilars Drug Introduction
11.15.4 Dr Reddy’s Revenue in Biosimilars Drug Business (2020-2025)
11.15.5 Dr Reddy’s Recent Development
11.16 Celgen Biopharma
11.16.1 Celgen Biopharma Company Details
11.16.2 Celgen Biopharma Business Overview
11.16.3 Celgen Biopharma Biosimilars Drug Introduction
11.16.4 Celgen Biopharma Revenue in Biosimilars Drug Business (2020-2025)
11.16.5 Celgen Biopharma Recent Development
11.17 Eli Lilly
11.17.1 Eli Lilly Company Details
11.17.2 Eli Lilly Business Overview
11.17.3 Eli Lilly Biosimilars Drug Introduction
11.17.4 Eli Lilly Revenue in Biosimilars Drug Business (2020-2025)
11.17.5 Eli Lilly Recent Development
11.18 Sanofi
11.18.1 Sanofi Company Details
11.18.2 Sanofi Business Overview
11.18.3 Sanofi Biosimilars Drug Introduction
11.18.4 Sanofi Revenue in Biosimilars Drug Business (2020-2025)
11.18.5 Sanofi Recent Development
11.19 Geropharm
11.19.1 Geropharm Company Details
11.19.2 Geropharm Business Overview
11.19.3 Geropharm Biosimilars Drug Introduction
11.19.4 Geropharm Revenue in Biosimilars Drug Business (2020-2025)
11.19.5 Geropharm Recent Development
11.20 Biocon
11.20.1 Biocon Company Details
11.20.2 Biocon Business Overview
11.20.3 Biocon Biosimilars Drug Introduction
11.20.4 Biocon Revenue in Biosimilars Drug Business (2020-2025)
11.20.5 Biocon Recent Development
11.21 Wockhardt
11.21.1 Wockhardt Company Details
11.21.2 Wockhardt Business Overview
11.21.3 Wockhardt Biosimilars Drug Introduction
11.21.4 Wockhardt Revenue in Biosimilars Drug Business (2020-2025)
11.21.5 Wockhardt Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Qilu Pharmaceutical
Zhejiang Hisun
Innovent Biologics
Jiangsu Hengrui
Gan & Lee
Tonghua Dongbao
United Laboratory
3SBio Inc
Luye Pharma
Celltrion
Pfizer Inc
Novartis
Dr. Reddy's
Celgen Biopharma
Eli Lilly
Sanofi
Geropharm
Biocon Ltd.
WOCKHARDT
Bio-Thera
Shanghai Henlius
List of Tables
 Table 1. Global Biosimilars Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Monoclonal Antibodies
 Table 3. Key Players of Insulin
 Table 4. Key Players of Others
 Table 5. Global Biosimilars Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Biosimilars Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Biosimilars Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Biosimilars Drug Market Share by Region (2020-2025)
 Table 9. Global Biosimilars Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Biosimilars Drug Market Share by Region (2026-2031)
 Table 11. Biosimilars Drug Market Trends
 Table 12. Biosimilars Drug Market Drivers
 Table 13. Biosimilars Drug Market Challenges
 Table 14. Biosimilars Drug Market Restraints
 Table 15. Global Biosimilars Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Biosimilars Drug Market Share by Players (2020-2025)
 Table 17. Global Top Biosimilars Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars Drug as of 2024)
 Table 18. Ranking of Global Top Biosimilars Drug Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Biosimilars Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Biosimilars Drug, Headquarters and Area Served
 Table 21. Global Key Players of Biosimilars Drug, Product and Application
 Table 22. Global Key Players of Biosimilars Drug, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Biosimilars Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Biosimilars Drug Revenue Market Share by Type (2020-2025)
 Table 26. Global Biosimilars Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Biosimilars Drug Revenue Market Share by Type (2026-2031)
 Table 28. Global Biosimilars Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Biosimilars Drug Revenue Market Share by Application (2020-2025)
 Table 30. Global Biosimilars Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Biosimilars Drug Revenue Market Share by Application (2026-2031)
 Table 32. North America Biosimilars Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Biosimilars Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Biosimilars Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Biosimilars Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Biosimilars Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Biosimilars Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Biosimilars Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Biosimilars Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Biosimilars Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Biosimilars Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Biosimilars Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Biosimilars Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Biosimilars Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Biosimilars Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Biosimilars Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Qilu Pharmaceutical Company Details
 Table 48. Qilu Pharmaceutical Business Overview
 Table 49. Qilu Pharmaceutical Biosimilars Drug Product
 Table 50. Qilu Pharmaceutical Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 51. Qilu Pharmaceutical Recent Development
 Table 52. Bio-Thera Company Details
 Table 53. Bio-Thera Business Overview
 Table 54. Bio-Thera Biosimilars Drug Product
 Table 55. Bio-Thera Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 56. Bio-Thera Recent Development
 Table 57. Zhejiang Hisun Company Details
 Table 58. Zhejiang Hisun Business Overview
 Table 59. Zhejiang Hisun Biosimilars Drug Product
 Table 60. Zhejiang Hisun Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 61. Zhejiang Hisun Recent Development
 Table 62. Shanghai Henlius Company Details
 Table 63. Shanghai Henlius Business Overview
 Table 64. Shanghai Henlius Biosimilars Drug Product
 Table 65. Shanghai Henlius Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 66. Shanghai Henlius Recent Development
 Table 67. Innovent Biologics Company Details
 Table 68. Innovent Biologics Business Overview
 Table 69. Innovent Biologics Biosimilars Drug Product
 Table 70. Innovent Biologics Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 71. Innovent Biologics Recent Development
 Table 72. Jiangsu Hengrui Company Details
 Table 73. Jiangsu Hengrui Business Overview
 Table 74. Jiangsu Hengrui Biosimilars Drug Product
 Table 75. Jiangsu Hengrui Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 76. Jiangsu Hengrui Recent Development
 Table 77. Gan&Lee Company Details
 Table 78. Gan&Lee Business Overview
 Table 79. Gan&Lee Biosimilars Drug Product
 Table 80. Gan&Lee Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 81. Gan&Lee Recent Development
 Table 82. Tonghua Dongbao Company Details
 Table 83. Tonghua Dongbao Business Overview
 Table 84. Tonghua Dongbao Biosimilars Drug Product
 Table 85. Tonghua Dongbao Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 86. Tonghua Dongbao Recent Development
 Table 87. United Laboratory Company Details
 Table 88. United Laboratory Business Overview
 Table 89. United Laboratory Biosimilars Drug Product
 Table 90. United Laboratory Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 91. United Laboratory Recent Development
 Table 92. 3SBIO Company Details
 Table 93. 3SBIO Business Overview
 Table 94. 3SBIO Biosimilars Drug Product
 Table 95. 3SBIO Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 96. 3SBIO Recent Development
 Table 97. Luye Pharma Company Details
 Table 98. Luye Pharma Business Overview
 Table 99. Luye Pharma Biosimilars Drug Product
 Table 100. Luye Pharma Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 101. Luye Pharma Recent Development
 Table 102. Celltrion Company Details
 Table 103. Celltrion Business Overview
 Table 104. Celltrion Biosimilars Drug Product
 Table 105. Celltrion Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 106. Celltrion Recent Development
 Table 107. Pfizer Company Details
 Table 108. Pfizer Business Overview
 Table 109. Pfizer Biosimilars Drug Product
 Table 110. Pfizer Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 111. Pfizer Recent Development
 Table 112. Novartis Company Details
 Table 113. Novartis Business Overview
 Table 114. Novartis Biosimilars Drug Product
 Table 115. Novartis Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 116. Novartis Recent Development
 Table 117. Dr Reddy’s Company Details
 Table 118. Dr Reddy’s Business Overview
 Table 119. Dr Reddy’s Biosimilars Drug Product
 Table 120. Dr Reddy’s Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 121. Dr Reddy’s Recent Development
 Table 122. Celgen Biopharma Company Details
 Table 123. Celgen Biopharma Business Overview
 Table 124. Celgen Biopharma Biosimilars Drug Product
 Table 125. Celgen Biopharma Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 126. Celgen Biopharma Recent Development
 Table 127. Eli Lilly Company Details
 Table 128. Eli Lilly Business Overview
 Table 129. Eli Lilly Biosimilars Drug Product
 Table 130. Eli Lilly Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 131. Eli Lilly Recent Development
 Table 132. Sanofi Company Details
 Table 133. Sanofi Business Overview
 Table 134. Sanofi Biosimilars Drug Product
 Table 135. Sanofi Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 136. Sanofi Recent Development
 Table 137. Geropharm Company Details
 Table 138. Geropharm Business Overview
 Table 139. Geropharm Biosimilars Drug Product
 Table 140. Geropharm Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 141. Geropharm Recent Development
 Table 142. Biocon Company Details
 Table 143. Biocon Business Overview
 Table 144. Biocon Biosimilars Drug Product
 Table 145. Biocon Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 146. Biocon Recent Development
 Table 147. Wockhardt Company Details
 Table 148. Wockhardt Business Overview
 Table 149. Wockhardt Biosimilars Drug Product
 Table 150. Wockhardt Revenue in Biosimilars Drug Business (2020-2025) & (US$ Million)
 Table 151. Wockhardt Recent Development
 Table 152. Research Programs/Design for This Report
 Table 153. Key Data Information from Secondary Sources
 Table 154. Key Data Information from Primary Sources
 Table 155. Authors List of This Report


List of Figures
 Figure 1. Biosimilars Drug Picture
 Figure 2. Global Biosimilars Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Biosimilars Drug Market Share by Type: 2024 VS 2031
 Figure 4. Monoclonal Antibodies Features
 Figure 5. Insulin Features
 Figure 6. Others Features
 Figure 7. Global Biosimilars Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Biosimilars Drug Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. Retail Pharmacy Case Studies
 Figure 11. Other Case Studies
 Figure 12. Biosimilars Drug Report Years Considered
 Figure 13. Global Biosimilars Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Biosimilars Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Biosimilars Drug Market Share by Region: 2024 VS 2031
 Figure 16. Global Biosimilars Drug Market Share by Players in 2024
 Figure 17. Global Top Biosimilars Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilars Drug as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Biosimilars Drug Revenue in 2024
 Figure 19. North America Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Biosimilars Drug Market Share by Country (2020-2031)
 Figure 21. United States Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Biosimilars Drug Market Share by Country (2020-2031)
 Figure 25. Germany Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Biosimilars Drug Market Share by Region (2020-2031)
 Figure 33. China Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Biosimilars Drug Market Share by Country (2020-2031)
 Figure 41. Mexico Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Biosimilars Drug Market Share by Country (2020-2031)
 Figure 45. Turkey Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Biosimilars Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Qilu Pharmaceutical Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 49. Bio-Thera Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 50. Zhejiang Hisun Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 51. Shanghai Henlius Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 52. Innovent Biologics Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 53. Jiangsu Hengrui Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 54. Gan&Lee Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 55. Tonghua Dongbao Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 56. United Laboratory Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 57. 3SBIO Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 58. Luye Pharma Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 59. Celltrion Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 60. Pfizer Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 61. Novartis Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 62. Dr Reddy’s Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 63. Celgen Biopharma Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 64. Eli Lilly Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 65. Sanofi Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 66. Geropharm Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 67. Biocon Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 68. Wockhardt Revenue Growth Rate in Biosimilars Drug Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Biosimilar and Interchangeable Biologics Market Research Report 2024
Global Biosimilars and Innovative Biological Drugs Market Research Report 2024
Global Generic vs Innovator Drugs Market Research Report 2024
Biosimilar Insulin Market
Global Monoclonal antibodies mAbs Biosimilars Market Research Report 2024
Global Biosimilar Antibodies Market Research Report 2024
Global Interchangeable Biological Products Market Research Report 2024
Global Psoriasis Biosimilar Market Research Report 2024
Global Interchangeable Biosimilars Market Research Report 2024
Innovative Biologics and Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Osteoporosis Biosimilars Market Research Report 2025
Biosimilar of Remicade Market
Humira Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Innovations in Biologics and Biosimilars Market Research Report 2024
Global Biologics and Biosimilars Market Research Report 2025
Global Rituximab Biosimilars Market Research Report 2025
Innovative Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Insulin Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biotech Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions